Effect of mannitol and plasma on the cytotoxicity of cisplatin

A soft agar cell culture for human granulocyte precursor cells (CFU-c) was used to assess the cytotoxic effect of cisplatin before and after preincubating the drug with either mannitol and/or fresh human plasma. Consistent growth inhibition of CFU-c was found with survival of 87, 64 and 34% at cispl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer & clinical oncology 1983-04, Vol.19 (4), p.515-518
Hauptverfasser: Holdener, Eduard E., Park, Chan H., Belt, Robert J., Stephens, Ronald L., Hoogstraten, Barth
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 518
container_issue 4
container_start_page 515
container_title European journal of cancer & clinical oncology
container_volume 19
creator Holdener, Eduard E.
Park, Chan H.
Belt, Robert J.
Stephens, Ronald L.
Hoogstraten, Barth
description A soft agar cell culture for human granulocyte precursor cells (CFU-c) was used to assess the cytotoxic effect of cisplatin before and after preincubating the drug with either mannitol and/or fresh human plasma. Consistent growth inhibition of CFU-c was found with survival of 87, 64 and 34% at cisplatin concentrations of 10 −7 M, 10 −6 M and 10 −5 M respectively. Dose-related survival was not changed by preincubating cisplatin with mannitol in molar ratios of 1:100 and 1:1000 for 4 and 24 hr. Preincubating 10 −5 M cisplatin with human plasma increased CFU-c survival corresponding to a loss of activity of 92 and 98% after 4- and 24-hr preincubations respectively. No significant difference in survival of CFU-c was noted whether bone marrow cells were exposed to cisplatin in human plasma or in the ultrafiltrate of human plasma. Mannitol did not change the decrease in cisplatin activity due to plasma protein binding. These data indicate that the cytotoxic effect of cisplatin can be reduced by exposure to human plasma but not to mannitol.
doi_str_mv 10.1016/0277-5379(83)90115-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80522518</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0277537983901153</els_id><sourcerecordid>80522518</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-350c8f55216db02c8e33f8d4a3e6542a002afc52eb5864cd0e7227dd420902e43</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhnNQaq3-A4U9iR5WJ1-76aUgpX5AwYueQ5rMYmR3Uzep2H_vri096mlg5nlnhoeQCwq3FGhxB6wsc8nL6bXiN1OgVOb8iIwP7RNyGuMHAFNC8hEZFQJKJcSYzBZVhTZlocoa07Y-hTozrcvWtYmNyUKbpXfM7DaFFL699Wk7oNbHHki-PSPHlakjnu_rhLw9LF7nT_ny5fF5fr_MLQeeci7BqkpKRgu3AmYVcl4pJwzHQgpm-sdMZSXDlVSFsA6wZKx0TjCYAkPBJ-Rqt3fdhc8NxqQbHy3WtWkxbKJWIBmTVP0LUl5KkNOiB8UOtF2IscNKrzvfmG6rKejBqR7k6UGeVlz_OtW8j13u929WDbpDaC-0n892c-xtfHnsdLQeW4vOd71n7YL_-8APEISGaQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>13750596</pqid></control><display><type>article</type><title>Effect of mannitol and plasma on the cytotoxicity of cisplatin</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Holdener, Eduard E. ; Park, Chan H. ; Belt, Robert J. ; Stephens, Ronald L. ; Hoogstraten, Barth</creator><creatorcontrib>Holdener, Eduard E. ; Park, Chan H. ; Belt, Robert J. ; Stephens, Ronald L. ; Hoogstraten, Barth</creatorcontrib><description>A soft agar cell culture for human granulocyte precursor cells (CFU-c) was used to assess the cytotoxic effect of cisplatin before and after preincubating the drug with either mannitol and/or fresh human plasma. Consistent growth inhibition of CFU-c was found with survival of 87, 64 and 34% at cisplatin concentrations of 10 −7 M, 10 −6 M and 10 −5 M respectively. Dose-related survival was not changed by preincubating cisplatin with mannitol in molar ratios of 1:100 and 1:1000 for 4 and 24 hr. Preincubating 10 −5 M cisplatin with human plasma increased CFU-c survival corresponding to a loss of activity of 92 and 98% after 4- and 24-hr preincubations respectively. No significant difference in survival of CFU-c was noted whether bone marrow cells were exposed to cisplatin in human plasma or in the ultrafiltrate of human plasma. Mannitol did not change the decrease in cisplatin activity due to plasma protein binding. These data indicate that the cytotoxic effect of cisplatin can be reduced by exposure to human plasma but not to mannitol.</description><identifier>ISSN: 0277-5379</identifier><identifier>DOI: 10.1016/0277-5379(83)90115-3</identifier><identifier>PMID: 6407844</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Agar ; Bone Marrow - drug effects ; Bone Marrow Cells ; Cell Survival - drug effects ; Cells, Cultured ; Cisplatin - pharmacology ; Colony-Forming Units Assay ; Dose-Response Relationship, Drug ; Humans ; Mannitol - pharmacology ; Plasma</subject><ispartof>European journal of cancer &amp; clinical oncology, 1983-04, Vol.19 (4), p.515-518</ispartof><rights>1983</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c303t-350c8f55216db02c8e33f8d4a3e6542a002afc52eb5864cd0e7227dd420902e43</citedby><cites>FETCH-LOGICAL-c303t-350c8f55216db02c8e33f8d4a3e6542a002afc52eb5864cd0e7227dd420902e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6407844$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Holdener, Eduard E.</creatorcontrib><creatorcontrib>Park, Chan H.</creatorcontrib><creatorcontrib>Belt, Robert J.</creatorcontrib><creatorcontrib>Stephens, Ronald L.</creatorcontrib><creatorcontrib>Hoogstraten, Barth</creatorcontrib><title>Effect of mannitol and plasma on the cytotoxicity of cisplatin</title><title>European journal of cancer &amp; clinical oncology</title><addtitle>Eur J Cancer Clin Oncol</addtitle><description>A soft agar cell culture for human granulocyte precursor cells (CFU-c) was used to assess the cytotoxic effect of cisplatin before and after preincubating the drug with either mannitol and/or fresh human plasma. Consistent growth inhibition of CFU-c was found with survival of 87, 64 and 34% at cisplatin concentrations of 10 −7 M, 10 −6 M and 10 −5 M respectively. Dose-related survival was not changed by preincubating cisplatin with mannitol in molar ratios of 1:100 and 1:1000 for 4 and 24 hr. Preincubating 10 −5 M cisplatin with human plasma increased CFU-c survival corresponding to a loss of activity of 92 and 98% after 4- and 24-hr preincubations respectively. No significant difference in survival of CFU-c was noted whether bone marrow cells were exposed to cisplatin in human plasma or in the ultrafiltrate of human plasma. Mannitol did not change the decrease in cisplatin activity due to plasma protein binding. These data indicate that the cytotoxic effect of cisplatin can be reduced by exposure to human plasma but not to mannitol.</description><subject>Adult</subject><subject>Agar</subject><subject>Bone Marrow - drug effects</subject><subject>Bone Marrow Cells</subject><subject>Cell Survival - drug effects</subject><subject>Cells, Cultured</subject><subject>Cisplatin - pharmacology</subject><subject>Colony-Forming Units Assay</subject><subject>Dose-Response Relationship, Drug</subject><subject>Humans</subject><subject>Mannitol - pharmacology</subject><subject>Plasma</subject><issn>0277-5379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhnNQaq3-A4U9iR5WJ1-76aUgpX5AwYueQ5rMYmR3Uzep2H_vri096mlg5nlnhoeQCwq3FGhxB6wsc8nL6bXiN1OgVOb8iIwP7RNyGuMHAFNC8hEZFQJKJcSYzBZVhTZlocoa07Y-hTozrcvWtYmNyUKbpXfM7DaFFL699Wk7oNbHHki-PSPHlakjnu_rhLw9LF7nT_ny5fF5fr_MLQeeci7BqkpKRgu3AmYVcl4pJwzHQgpm-sdMZSXDlVSFsA6wZKx0TjCYAkPBJ-Rqt3fdhc8NxqQbHy3WtWkxbKJWIBmTVP0LUl5KkNOiB8UOtF2IscNKrzvfmG6rKejBqR7k6UGeVlz_OtW8j13u929WDbpDaC-0n892c-xtfHnsdLQeW4vOd71n7YL_-8APEISGaQ</recordid><startdate>198304</startdate><enddate>198304</enddate><creator>Holdener, Eduard E.</creator><creator>Park, Chan H.</creator><creator>Belt, Robert J.</creator><creator>Stephens, Ronald L.</creator><creator>Hoogstraten, Barth</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7T5</scope><scope>7U2</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>198304</creationdate><title>Effect of mannitol and plasma on the cytotoxicity of cisplatin</title><author>Holdener, Eduard E. ; Park, Chan H. ; Belt, Robert J. ; Stephens, Ronald L. ; Hoogstraten, Barth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-350c8f55216db02c8e33f8d4a3e6542a002afc52eb5864cd0e7227dd420902e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Adult</topic><topic>Agar</topic><topic>Bone Marrow - drug effects</topic><topic>Bone Marrow Cells</topic><topic>Cell Survival - drug effects</topic><topic>Cells, Cultured</topic><topic>Cisplatin - pharmacology</topic><topic>Colony-Forming Units Assay</topic><topic>Dose-Response Relationship, Drug</topic><topic>Humans</topic><topic>Mannitol - pharmacology</topic><topic>Plasma</topic><toplevel>online_resources</toplevel><creatorcontrib>Holdener, Eduard E.</creatorcontrib><creatorcontrib>Park, Chan H.</creatorcontrib><creatorcontrib>Belt, Robert J.</creatorcontrib><creatorcontrib>Stephens, Ronald L.</creatorcontrib><creatorcontrib>Hoogstraten, Barth</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer &amp; clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holdener, Eduard E.</au><au>Park, Chan H.</au><au>Belt, Robert J.</au><au>Stephens, Ronald L.</au><au>Hoogstraten, Barth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of mannitol and plasma on the cytotoxicity of cisplatin</atitle><jtitle>European journal of cancer &amp; clinical oncology</jtitle><addtitle>Eur J Cancer Clin Oncol</addtitle><date>1983-04</date><risdate>1983</risdate><volume>19</volume><issue>4</issue><spage>515</spage><epage>518</epage><pages>515-518</pages><issn>0277-5379</issn><abstract>A soft agar cell culture for human granulocyte precursor cells (CFU-c) was used to assess the cytotoxic effect of cisplatin before and after preincubating the drug with either mannitol and/or fresh human plasma. Consistent growth inhibition of CFU-c was found with survival of 87, 64 and 34% at cisplatin concentrations of 10 −7 M, 10 −6 M and 10 −5 M respectively. Dose-related survival was not changed by preincubating cisplatin with mannitol in molar ratios of 1:100 and 1:1000 for 4 and 24 hr. Preincubating 10 −5 M cisplatin with human plasma increased CFU-c survival corresponding to a loss of activity of 92 and 98% after 4- and 24-hr preincubations respectively. No significant difference in survival of CFU-c was noted whether bone marrow cells were exposed to cisplatin in human plasma or in the ultrafiltrate of human plasma. Mannitol did not change the decrease in cisplatin activity due to plasma protein binding. These data indicate that the cytotoxic effect of cisplatin can be reduced by exposure to human plasma but not to mannitol.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>6407844</pmid><doi>10.1016/0277-5379(83)90115-3</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0277-5379
ispartof European journal of cancer & clinical oncology, 1983-04, Vol.19 (4), p.515-518
issn 0277-5379
language eng
recordid cdi_proquest_miscellaneous_80522518
source MEDLINE; Alma/SFX Local Collection
subjects Adult
Agar
Bone Marrow - drug effects
Bone Marrow Cells
Cell Survival - drug effects
Cells, Cultured
Cisplatin - pharmacology
Colony-Forming Units Assay
Dose-Response Relationship, Drug
Humans
Mannitol - pharmacology
Plasma
title Effect of mannitol and plasma on the cytotoxicity of cisplatin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T20%3A29%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20mannitol%20and%20plasma%20on%20the%20cytotoxicity%20of%20cisplatin&rft.jtitle=European%20journal%20of%20cancer%20&%20clinical%20oncology&rft.au=Holdener,%20Eduard%20E.&rft.date=1983-04&rft.volume=19&rft.issue=4&rft.spage=515&rft.epage=518&rft.pages=515-518&rft.issn=0277-5379&rft_id=info:doi/10.1016/0277-5379(83)90115-3&rft_dat=%3Cproquest_cross%3E80522518%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=13750596&rft_id=info:pmid/6407844&rft_els_id=0277537983901153&rfr_iscdi=true